Consensus Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Real-time Estimate Cboe Europe Other stock markets 07:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
9.51 ^CHF	+0.11%		+4.28%	-3.16%

Apr. 25	Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows	MT
Apr. 25	Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Santhera Pharmaceuticals Holding AG

Price target over the last 5 years

History of analyst recommendation changes

81b35f2ea43353f6fada46734193.23hVJ0uhRpKRd6j8JkWtNkBw2p5T8_ey0deSJyAZn1w.4ggjawaTN_aiRt6VXwjpfiFDg9Q_qZLigqGiYEJT3Te4J2JvJM9w2aAvnA~e7392adb3e0ffef052c350cd4408f556

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.5 CHF

Average target price

30 CHF

Spread / Average Target

+215.79%

High Price Target

30 CHF

Spread / Highest target

+215.79%

Low Price Target

30 CHF

Spread / Lowest Target

+215.79%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar